BeLiver is a spin-off from the oncology laboratory at the University of Bordeaux, uniting the complementary expertise of its co-founders: Dr. Frédéric Saltel, an oncology expert, Dr. Anne-Aurélie Raymond, a specialist in mass spectrometry and bioinformatics, and Madeleine Moscatelli, an entrepreneur passionate about biotechnology.
Together, they share a common vision: improving quality of life of cancer patients by paving a new road to cancer care with an innovative rational approach giving oncologists a new decision tool to choose the right treatment for their patients.
With the active support of oncologists, they transformed years of cutting-edge research into a practical solution, to offer new hope to patients battling cancer.
This technology will be the first step
towards truly personalised medicine
in digestive oncology
Bordeaux University Hospital KOL
in charge of guidelines for the treatment of liver cancer
AP-HP Henri Mondor
Head of Department
of Specialised Pathology IA
© ALL RIGHTS RESERVED Legal informationCookie policy (EU)Privacy statement (EU)
